Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs”
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and gastrointestinal issues. Demand for weight-loss medications, including popular brands like Ozempic and Wegovy,
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity for weight loss, doctors are observing a ...
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...
From science-backed supplements to insurance-covered nutrition therapy, here's your complete guide to effective weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback